Anti-TNF in Rheumatic Diseases: Inventory and Outlook
With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare professionals (HCP) are being presented with an expanding armamentarium of treatment options that can increase patient access to effective biologic therapies...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2018-07-01
|
| Series: | European Medical Journal Rheumatology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/rheumatology/symposium/anti-tnf-in-rheumatic-diseases-inventory-and-outlook/ |